Friday, September 14, 2018 1:04:00 PM
The company just completed the first phase of a debt restructuring program that moved more than $11.8M in liabilities into long-term preferred equity.
Based on my interpretation of the recent 8-K, the company was required to increase the AS to accommodate the potential conversion of the Preferred shares. From what I understand from the attachments in the 8-K, the company was required to reserve in its authorized and unissued common share an amount of shares equal to 120% of the potential conversion of all Preferred shares.
Considering the company converted nearly $12 million in debt to Preferred shares, the AS increase was much smaller than I expected. Furthermore, the CEO stated on the recent conference call that that may be in a position to buyback the preferred shares before they convert.
The company has gone to great lengths to eliminate convertible debt. They have two small notes remaining totaling $235K that they intend to pay back in cash.
Links to 8-K (with attachments)...
https://www.otcmarkets.com/filing/html?id=12953802&guid=Td-ZUKfyqmOprth
Link to Conference call summary as confirmed by IR...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143147458
DSGT
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM